Identification of Predictive ERBB Mutations by Leveraging Publicly Available Cell Line Databases.
- DOI
- 10.1158/1535-7163.mct-20-0590
- Published
- 2021 Mar
- Container
- Molecular cancer therapeutics
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1158/1535-7163.mct-20-0590,
title = {Identification of Predictive ERBB Mutations by Leveraging Publicly Available Cell Line Databases.},
author = {Koivu MKA and Chakroborty D and Tamirat MZ and Johnson MS and Kurppa KJ and Elenius K},
year = {2021},
journal = {Molecular cancer therapeutics},
doi = {10.1158/1535-7163.mct-20-0590},
url = {https://doi.org/10.1158/1535-7163.mct-20-0590}
}RIS
TY - JOUR TI - Identification of Predictive ERBB Mutations by Leveraging Publicly Available Cell Line Databases. AU - Koivu MKA AU - Chakroborty D AU - Tamirat MZ AU - Johnson MS AU - Kurppa KJ AU - Elenius K PY - 2021 JO - Molecular cancer therapeutics DO - 10.1158/1535-7163.mct-20-0590 UR - https://doi.org/10.1158/1535-7163.mct-20-0590 ER -
APA
MKA, K., D, C., MZ, T., MS, J., KJ, K., & K, E. (2021). Identification of Predictive ERBB Mutations by Leveraging Publicly Available Cell Line Databases.. Molecular cancer therapeutics. https://doi.org/10.1158/1535-7163.mct-20-0590
Source records
- pubmed · retrieved 2026-09-26T21:25:04.433Z